Results for Pharmacokinetic Studies

1 - 9 of 9

Dr. Getz develops and applies advanced methods to enable epidemiologic research that aims to optimize the treatment and supportive care of children with cancer by balancing the therapeutic benefits and toxicity risks with an emphasis in cardio-oncology.

E-mail:

getzk [at] chop.edu

Pediatric Leukemia Expert Named CCCR Director

Published on

Dec 23, 2014

in Cornerstone Blog

Stephen P. Hunger, MD, a nationally prominent specialist in children’s cancer, has been named the new director of the Center for Childhood Cancer Research (CCCR) and chief of the Division of Oncology.

Downes Laboratory

The Downes Lab studies pediatric antimicrobial pharmacokinetics/pharmacodynamics (PK/PD) and pharmacoepidemiology with a focus on the relationship between antibiotic dosing/exposures and outcomes, including clinical cure, adverse events, and the development of antimicrobial resistance.

Upadacitinib Trial for Polyarticular JIA

The purpose of this study is to see if a new investigational drug (Upadacitinib) is safe and well tolerated and also to determine the appropriate dose for subjects with polyarticular course juvenile arthritis (pcJIA).

Comparative Medicine Services Core Services

Views a list of services provided by the Comparative Medicine Services Core.

Investigational Drug Service

The Investigational Drug Service (IDS) component of Children’s Hospital of Philadelphia's Department of Pharmacy Services complements the institution's clinical research mission in advancing new therapeutic modalities.

Comparative Medicine Services Core

The Comparative Medicine Services Core partners with and guides investigators through the process of translating their wet bench research into clinical care to improve the lives of patients and families.

Advancement of Hyperinsulinism Care and Research

Revolutionizing our understanding of the genetic causes and mechanisms of hyperinsulinism, developing diagnostic tools for a precision-medicine approach to treatment, and discovering new treatment options.

Cancer Pharmacology Laboratory

The Cancer Pharmacology Laboratory supports clinical trials of new mechanistically targeted and immune-based anticancer drugs by conducting pre-clinical and clinical pharmacology studies of the agents. The lab also studies conventional anticancer drugs to develop more rational and effective dosing methods, and the lab team is developing ci